A Phase I study of MEDI-575, a PDGFRα monoclonal antibody, in Japanese patients with advanced solid tumors

被引：0

作者：

Haruyasu Murakami

Masafumi Ikeda

Takuji Okusaka

Yoshitaka Inaba

Haruo Iguchi

Katsuro Yagawa

Nobuyuki Yamamoto

机构：

[1] Shizuoka Cancer Center,Division of Thoracic Oncology

[2] National Cancer Center East Hospital,Department of Hepatobiliary and Pancreatic Oncology

[3] National Cancer Center Hospital,Division of Hepatobiliary and Pancreatic Oncology

[4] Aichi Cancer Center Hospital,Department of Diagnostic and Interventional Radiology

[5] Shikoku Cancer Center,Clinical Research Institute

[6] AstraZeneca KK,R&D, Clinical Science Department

[7] Wakayama Medical University School of Medicine,Third Department of Internal Medicine

来源：

Cancer Chemotherapy and Pharmacology | 2015年 / 76卷

关键词：

MEDI-575; PDGFRα monoclonal antibody; Safety; Pharmacokinetics; Japan;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：631 / 639

页数：8

共 109 条